Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

Similar articles for PubMed (Select 9605126)

1.

Autocrine and paracrine apoptosis are mediated by differential regulation of Fas ligand activity in two distinct Jurkat T cell populations.

Su X, Cheng J, Liu W, Liu C, Wang Z, Yang P, Zhou T, Mountz JD.

J Immunol. 1998 Jun 1;160(11):5288-93.

2.

Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.

Hoves S, Krause SW, Halbritter D, Zhang HG, Mountz JD, Schölmerich J, Fleck M.

J Immunol. 2003 Jun 1;170(11):5406-13.

3.

Expression and function of Fas and Fas ligand on peripheral blood lymphocytes in normal subjects.

Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Nakashima T, Kawabe Y, Nagataki S.

J Lab Clin Med. 1998 Nov;132(5):404-13.

PMID:
9823934
4.
5.

Protein kinase ctheta cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death.

Villalba M, Kasibhatla S, Genestier L, Mahboubi A, Green DR, Altman A.

J Immunol. 1999 Dec 1;163(11):5813-9.

6.

NF-kappa B-dependent Fas ligand expression.

Hsu SC, Gavrilin MA, Lee HH, Wu CC, Han SH, Lai MZ.

Eur J Immunol. 1999 Sep;29(9):2948-56.

PMID:
10508269
7.

Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.

Huerta-Yepez S, Vega M, Garban H, Bonavida B.

Clin Immunol. 2006 Sep;120(3):297-309. Epub 2006 Jun 19.

PMID:
16784892
8.

Mechanisms of apoptosis in T cells from patients with renal cell carcinoma.

Uzzo RG, Rayman P, Kolenko V, Clark PE, Bloom T, Ward AM, Molto L, Tannenbaum C, Worford LJ, Bukowski R, Tubbs R, Hsi ED, Bander NH, Novick AC, Finke JH.

Clin Cancer Res. 1999 May;5(5):1219-29.

10.

Fas/FasL interaction is not involved in apoptosis of activated CD4+ T cells upon HIV-1 infection in vitro.

Yagi T, Sugimoto A, Tanaka M, Nagata S, Yasuda S, Yagita H, Kuriyama T, Takemori T, Tsunetsugu-Yokota Y.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Aug 1;18(4):307-15.

PMID:
9704935
11.

Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.

Arnold R, Seifert M, Asadullah K, Volk HD.

J Immunol. 1999 Jun 15;162(12):7140-7.

12.

Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.

Watanabe N, Arase H, Kurasawa K, Iwamoto I, Kayagaki N, Yagita H, Okumura K, Miyatake S, Saito T.

Eur J Immunol. 1997 Aug;27(8):1858-64.

PMID:
9295019
13.

Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.

Villunger A, Ghaffari-Tabrizi N, Tinhofer I, Krumböck N, Bauer B, Schneider T, Kasibhatla S, Greil R, Baier-Bitterlich G, Uberall F, Green DR, Baier G.

Eur J Immunol. 1999 Nov;29(11):3549-61.

PMID:
10556809
14.
15.

Adenoviral vector which delivers FasL-GFP fusion protein regulated by the tet-inducible expression system.

Rubinchik S, Ding R, Qiu AJ, Zhang F, Dong J.

Gene Ther. 2000 May;7(10):875-85.

16.

A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation.

Li-Weber M, Laur O, Hekele A, Coy J, Walczak H, Krammer PH.

Eur J Immunol. 1998 Aug;28(8):2373-83.

PMID:
9710215
17.
18.

HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.

Truman JP, Choqueux C, Tschopp J, Vedrenne J, Le Deist F, Charron D, Mooney N.

Blood. 1997 Mar 15;89(6):1996-2007.

20.

Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function.

Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, Dörken B.

Eur J Immunol. 1997 Apr;27(4):1029-34.

PMID:
9130660
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk